Covid-19 Live Updates: U.S. Breaks Single-Day Record for New Cases as Number Nears 200,000

Advertisement

BEGIN ARTICLE PREVIEW:

Here’s what you need to know: Mary Goode preparing to do a blood test on a patient at the trial site for Regeneron and Eli Lilly in Mesa, Ariz., in August.Credit…Adriana Zehbrauskas for The New York TimesThe Food and Drug Administration has granted emergency authorization for the experimental antibody treatment given to President Trump shortly after he learned he had the coronavirus, giving doctors another option to treat patients as cases across the country continue to rise.The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise in early studies at keeping the infection in check, reducing medical visits for patients who get the drug early in the course of their disease. A similar treatment, made by Eli Lilly, was given emergency approval earlier this month.The emergency authorization for Regeneron’s drug is limited in scope: It is for people who have tested positive for the coronavirus and who are at high risk for developing severe Covid-19. And evidence so far suggests that Regeneron’s antibody treatment, like Eli Lilly’s, works best early in the course of the disease, before the virus has gained a foothold …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE